The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssetco Regulatory News (ASTO)

Share Price Information for Assetco (ASTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 32.00
Ask: 34.00
Change: 0.00 (0.00%)
Spread: 2.00 (6.25%)
Open: 33.00
High: 33.00
Low: 33.00
Prev. Close: 33.00
ASTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Interest in Rize ETF & update on Parmenion

20 Sep 2023 07:00

RNS Number : 0047N
AssetCo PLC
20 September 2023
 

20 September 2023

 

LEI: 213800LFMHKVNTZ7GV45

 

AssetCo plc

 

("AssetCo" or the "Company")

 

Sale of Interest in Rize ETF Limited ("Rize") and update on Parmenion

 

Sale of Interest in Rize ETF Limited

AssetCo is pleased to announce the disposal today of its 70% equity interest in Rize, a thematic ETF specialist, to ARK Invest LLC ("ARK"), a successful and established player in the ETF market based in the US. The sale agreement delivers consideration to AssetCo of an up-front payment of £2.625m, a deferred payment of £2.625m and an earn out provision, capped at £5.25m, which will operate over five years and is subject to a minimum, itself dependent upon certain conditions. In addition, the parties have agreed to work together to support the launch, on the Rize platform, of a number of ETF products for the River and Mercantile business, AssetCo's active equity asset management subsidiary.

 

The sale agreement accelerates the delivery of the potential of this fundamentally attractive business. Rize will become the hub for ARK's expansion into Europe and AssetCo is delighted to be aligned with ARK's and Rize's future success, both through the mechanism of the earn out agreement and the on-going ETF partnership. It also simplifies the AssetCo business model which will in turn reduce costs and improve profits.

 

As at 31 August 2023, Rize managed $452m in assets in 11 ETFs, all categorised as SFDR Article 8 or 9 compliant, domiciled in Dublin and distributed throughout Europe. ARK manages $25bn in ETFs and other products globally.

 

For the year ended 30 September 2022, Rize made a loss before tax of £2.5m on revenues of £1.9m, and as at 31 March 2023 gross assets were £0.75m. Completion of the deal is with immediate effect (Rize is not, itself, directly regulated), so that ARK takes immediate economic responsibility for the Rize business.

 

The value of goodwill attributed to Rize by AssetCo was £12m as at 31 March 2023 and AssetCo has decided to write that value down to £5m, before accounting for sale proceeds. Against this, the earn out from the sale agreement (capped at £5.25m) will emerge as a positive cash flow in future years.

 

Parmenion Capital Partners LLP ("Parmenion")

AssetCo is aware of the speculation around the value of its 30% equity interest in Parmenion that it acquired for an initial consideration of £20.6m in October 2021. Since acquiring the interest Parmenion has traded strongly in terms of AUM, revenue and profitability. Parmenion's shareholders have also received a number of approaches for the company.

 

As a result, AssetCo instructed an independent valuation of its equity interest in Parmenion that concluded that AssetCo's equity interest had a current value of between £75-90m. There are currently 141,009,943 AssetCo shares in the market which therefore equates to a value of between 53.2p and 63.8p per share for Parmenion alone.

 

Martin Gilbert, Executive Chair of AssetCo said:

 

"We have consistently said that we see enormous potential for the development of the ETF market in Europe and we continue to believe that Rize is well placed to be a key participant in that. We have come to the view that the best way for Rize to achieve that ambition is to partner with an established global player to do so. We are therefore delighted to have reached agreement with ARK Invest LLP to establish Rize as their hub for expansion into Europe. ARK are a committed and highly successful ETF player based in the US and we are extremely pleased to have reached an agreement that maintains our interest in the growth of their business for a period and also to partner with them to launch our own ETF products (managed by River and Mercantile Asset Management).

 

I am also pleased to share the results of an independent valuation of our interest in Parmenion which has been the result of some speculation in the market. The valuation confirms the considerable value of our stake and the strength of the Parmenion business."

 

Cathie D. Wood, Founder, CIO and CEO of ARK Invest added:

 

"Today's acquisition advances ARK Invest's commitment to offer high-quality thematic investment solutions to a global investor audience, particularly European investors who have not been able to access our products. We believe that the European ETF market presents a strong growth opportunity as new and younger investors continue to gain access to ETFs via the growth of digital platforms, and as active ETFs increase market share by meeting the demand for innovative investment exposures. We are delighted to welcome the talented Rize ETF team into the ARK family and to partner with AssetCo as part of this transaction. By merging the Rize Team's passion for thematic and sustainable index investing with ARK's innovative actively managed approach centered on disruptive innovation, we can offer our clients a more diverse array of investment options to invest in the future. Together, we will continue to educate and empower investors, helping them to achieve their long-term financial goals."

 

About ARK Invest LLC

ARK Invest LLC controls ARK Investment Management LLC which is a federally registered investment adviser and privately held investment firm. Specializing in thematic investing in disruptive innovation, the firm is rooted in over 40 years of experience in identifying and investing in innovations that should change the way the world works. Through its open research process, ARK identifies companies that it believes are leading and benefiting from cross-sector innovations such as robotics, energy storage, multiomic sequencing, artificial intelligence, and blockchain technology. ARK's investment strategies include Autonomous Technology and Robotics, Next Generation Internet, Genomic Revolution, Fintech Innovation, Space Exploration & Innovation, 3D Printing, Israel Innovative Technology, Venture Capital, and the overall ARK Disruptive Innovation Strategy. For more information about ARK, its offerings, and original research, please visit www.ark-invest.com.

 

For further information, please contact:

 

 

AssetCo plc

Gary Marshall, CFOO

Peter McKellar, Deputy Chairman

Tel: +44 (0) 7788 338157

Numis Securities Limited

Nominated adviser and joint broker

Giles Rolls / Charles Farquhar

Tel: +44 (0) 20 7260 1000

 

Panmure Gordon (UK) Limited

Joint broker

Atholl Tweedie

Tel: +44 (0) 20 7886 2906

 

 

H/Advisors Maitland

Neil Bennett

Rachel Cohen

Tel: +44 (0) 20 7379 55151

For further details, visit the website, www.assetco.com

 

Ticker: AIM: ASTO.L

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUROARONUKURR
Date   Source Headline
24th Apr 202411:55 amRNSResult of AGM
16th Apr 20247:00 amRNSDirectorate Change
27th Mar 20247:00 amRNSNotice of AGM
18th Mar 20247:00 amRNSPrelim Financial Statements for year ended 30/9/23
30th Jan 20247:00 amRNSIssue of Equity
9th Jan 20242:07 pmRNSDirector/PDMR Shareholding
6th Nov 20237:00 amRNSDirector/PDMR Shareholding
6th Oct 20237:00 amRNSSale of Interest in RMI LLP
2nd Oct 20237:00 amRNSAcquisition of Ocean Dial Asset Management Ltd
20th Sep 20237:00 amRNSSale of Interest in Rize ETF & update on Parmenion
15th Aug 20237:00 amRNSFCA approve acquisition of Ocean Dial by AssetCo
26th Jul 202310:17 amRNSDirector/PDMR Shareholding
21st Jun 20234:53 pmRNSDirector/PDMR Shareholding
20th Jun 20233:55 pmRNSDirectorate Change
14th Jun 20238:00 amRNSPost Offer Intention Statements
14th Jun 20237:00 amRNS2023 Half-year Report
3rd Apr 202312:05 pmRNSHolding(s) in Company
3rd Apr 202312:03 pmRNSHolding(s) in Company
30th Mar 202312:54 pmRNSResult of AGM
27th Mar 20232:02 pmRNSHolding(s) in Company
20th Mar 20233:30 pmRNSIssue of Shares out of Treasury
6th Mar 20237:00 amRNSAcquisition
2nd Mar 202310:09 amRNSNotice of AGM
23rd Feb 20233:12 pmRNSDirector/PDMR Shareholding
17th Feb 20239:57 amRNSTransaction in Own Shares
16th Feb 20237:00 amRNSPrelim results for the year ended 30 Sept 2022
3rd Feb 20234:00 pmRNSTransaction in Own Shares
1st Feb 20233:57 pmRNSTransaction in Own Shares
25th Jan 20235:37 pmRNSTransaction in Own Shares
24th Jan 20235:08 pmRNSTransaction in Own Shares
23rd Jan 20235:41 pmRNSTransaction in Own Shares
20th Jan 20235:06 pmRNSTransaction in Own Shares
19th Jan 20231:38 pmRNSTransaction in Own Shares
12th Jan 20235:54 pmRNSTransaction in Own Shares
11th Jan 20235:15 pmRNSTransaction in Own Shares
10th Jan 20233:10 pmRNSTransaction in Own Shares
9th Jan 20233:07 pmRNSTransaction in Own Shares
19th Dec 20223:17 pmRNSTransaction in Own Shares
15th Dec 20224:34 pmRNSTransaction in Own Shares
15th Dec 20224:32 pmRNSTransaction in Own Shares
13th Dec 20224:29 pmRNSTransaction in Own Shares
13th Dec 20227:00 amRNSTransaction in Own Shares
7th Dec 20224:25 pmRNSChange of Registered Office
29th Nov 202211:06 amRNSDividend Declaration - Replacement
28th Nov 20224:42 pmRNSHolding(s) in Company
24th Nov 20224:50 pmRNSTransaction in Own Shares
24th Nov 20224:43 pmRNSInterim Dividend Declaration
23rd Nov 20224:47 pmRNSTransaction in Own Shares
22nd Nov 20224:48 pmRNSTransaction in Own Shares
11th Nov 20229:33 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.